0001209191-18-036178.txt : 20180606
0001209191-18-036178.hdr.sgml : 20180606
20180606195730
ACCESSION NUMBER: 0001209191-18-036178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180604
FILED AS OF DATE: 20180606
DATE AS OF CHANGE: 20180606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vaughn James J
CENTRAL INDEX KEY: 0001649689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 18884978
MAIL ADDRESS:
STREET 1: C/O GENOMIC HEALTH, INC.
STREET 2: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-04
0
0001131324
GENOMIC HEALTH INC
GHDX
0001649689
Vaughn James J
301 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
Chief Commercial Officer
Common Stock
2018-06-04
4
M
0
9000
22.98
A
38655
D
Common Stock
2018-06-04
4
S
0
9000
43.8708
D
29655
D
Common Stock
2018-06-04
4
M
0
13500
27.48
A
43155
D
Common Stock
2018-06-04
4
S
0
10977
44.6691
D
32178
D
Common Stock
2018-06-04
4
S
0
2523
45.4689
D
29655
D
Common Stock
2018-06-04
4
M
0
20000
27.00
A
49655
D
Common Stock
2018-06-04
4
S
0
7552
46.0652
D
42103
D
Common Stock
2018-06-04
4
S
0
12448
46.8261
D
29655
D
Common Stock
2018-06-04
4
M
0
16268
28.05
A
45923
D
Common Stock
2018-06-04
4
S
0
9639
47.5743
D
36284
D
Common Stock
2018-06-04
4
S
0
6629
48.3285
D
29655
D
Common Stock
2018-06-04
4
M
0
12000
29.34
A
41655
D
Common Stock
2018-06-04
4
S
0
12000
48.5736
D
29655
D
Common Stock
2018-06-04
4
M
0
10000
17.18
A
39655
D
Common Stock
2018-06-04
4
S
0
10000
43.4088
D
29655
D
Common Stock
2018-06-04
4
S
0
8594
43.4209
D
21061
D
Common Stock
2018-06-04
4
S
0
4052
43.542
D
17009
D
Employee Stock Option (right to buy)
17.18
2018-06-04
4
M
0
10000
0.00
D
2020-02-18
Common Stock
0
0
D
Employee Stock Option (right to buy)
22.98
2018-06-04
4
M
0
9000
0.00
D
2021-01-27
Common Stock
0
0
D
Employee Stock Option (right to buy)
29.34
2018-06-04
4
M
0
12000
0.00
D
2022-02-05
Common Stock
0
0
D
Employee Stock Option (right to buy)
28.05
2018-06-04
4
M
0
16268
0.00
D
2023-01-31
Common Stock
0
3732
D
Employee Stock Option (right to buy) Holding
27.00
2018-06-04
4
M
0
20000
0.00
D
2026-02-16
Common Stock
0
41700
D
Employee Stock Option (right to buy) Holding
27.48
2018-06-04
4
M
0
13500
0.00
D
2027-01-31
Common Stock
0
40580
D
Includes an aggregate of 15,534 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 9, 2018.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $43.68 to $44.23.
Represents weighted average sale price. Actual sale prices ranged from $44.23 to $45.14.
Represents weighted average sale price. Actual sale prices ranged from $45.32 to $45.61.
Represents weighted average sale price. Actual sale prices ranged from $45.61 to $46.60.
Represents weighted average sale price. Actual sale prices ranged from $46.64 to $47.10.
Represents weighted average sale price. Actual sale prices ranged from $47.10 to $48.08.
Represents weighted average sale price. Actual sale prices ranged from $48.16 to $48.40.
Represents weighted average sale price. Actual sale prices ranged from $48.40 to $48.79.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 8, 2017.
Represents weighted average sale price. Actual sale prices ranged from $43.20 to $43.51.
Represents weighted average sale price. Actual sale prices ranged from $43.25 to $43.68.
Represents weighted average sale price. Actual sale prices ranged from $43.51 to $43.66.
The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on February 5, 2013, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on January 31, 2014, and becomes exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W.Radford, Attorney-in-fact
2018-06-06